Sodium/glucose cotransporter 5

Description:

Description
  • Accession: A0PJK1
  • Swissprot: SC5AA_HUMAN
  • Organism: Homo sapiens
  • Gene: SLC5A10
  • Target class: Transporter

Drug Relations:

empagliflozin
Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion. Bioactivity details MOA